75279-60-6 Usage
General Description
(6-Chloro-pyridin-2-yl)-acetonitrile is a chemical compound with the molecular formula C7H5ClN2. It is a derivative of pyridine and contains a chloride group at the 6th position and an acetonitrile group at the 2nd position. (6-Chloro-pyridin-2-yl)-acetonitrile is commonly used in the synthesis of pharmaceuticals, agrochemicals, and other organic compounds. It is also used as an intermediate in the preparation of various organic compounds and can be found in research and development laboratories. Additionally, it has potential applications in the field of material science and nanotechnology. Overall, (6-Chloro-pyridin-2-yl)-acetonitrile is a versatile chemical with several industrial and scientific uses.
Check Digit Verification of cas no
The CAS Registry Mumber 75279-60-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,5,2,7 and 9 respectively; the second part has 2 digits, 6 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 75279-60:
(7*7)+(6*5)+(5*2)+(4*7)+(3*9)+(2*6)+(1*0)=156
156 % 10 = 6
So 75279-60-6 is a valid CAS Registry Number.
InChI:InChI=1/C7H5ClN2/c8-7-3-1-2-6(10-7)4-5-9/h1-3H,4H2
75279-60-6Relevant articles and documents
PROSTAGLANDIN E2 (PGE2) EP4 RECEPTOR ANTAGONISTS
-
Page/Page column 78; 82; 159, (2021/04/10)
The present invention relates to novel compounds of formula (I) and pharmaceutical compositions containing these compounds. The compounds provided herein can act as prostaglandin E2 (PGE2) EP4 receptor antagonists, which renders them highly advantageous for use in therapy, particularly in the treatment or prevention of cancer, a neovascular eye disease, inflammatory pain, or an inflammatory disease, such as, e.g., multiple sclerosis, rheumatoid arthritis or endometriosis.
SEPIAPTERIN REDUCTASE INHIBITORS FOR THE TREATMENT OF PAIN
-
, (2011/05/05)
Disclosed herein are small molecule heterocyclic inhibitors of sepiapterin reductase (SPR), and pro-drugs and pharmaceutically acceptable salts thereof. The Also featured are pharmaceutical compositions of the compounds and uses of these compounds for the treatment or prevention of pain (e.g., inflammatory pain, nociceptive pain, functional pain, and neuropathic pain)